Shawn G. Hansen is an intellectual property partner based in our Los Angeles office and also maintains an office in our San Francisco office to work with clients and handle matters in Northern California. Shawn has built a successful track record over two decades of litigating and trying patent and other intellectual property cases in federal courts throughout the United States. He excels at synthesizing cutting edge technologies with legal strategy and is adept with technologies from software and semiconductors to pharmaceuticals and medical diagnostics. And he brings to bear exceptional capabilities to communicate complex technology to lay audiences and to keep the forest and the trees in focus at once.
I am dedicated to helping research institutions and other clients in the life sciences, technology, and media industries craft and execute IP strategies optimized for their business objectives, from high stakes litigation to tech transfer and licensing.
Tech Transfer Tactics | February 18, 2020
Intellectual Property partners Evan Langdon of Washington, DC, and Shawn Hansen and Seth Levy of Los Angeles co-wrote this article explaining how the U.S. International Trade Commission (ITC) can be a “powerfully effective venue” for patent protection. Evan, Shawn, and Seth are leading the NP team representing the University of California in an investigation pending at the ITC concerning LED lightbulb technology. Read the full article on techtransfercentral.com.
TotalRetail | February 13, 2020
This article analyzes the potential for lasting implications to the global supply chain as a result of the University of California’s (UC) patent enforcement campaign against several retailers selling filament LED lightbulbs. Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen are the lead attorneys representing UC.
Pacific Coast Business Times | February 07, 2020
The article mentions Nixon Peabody’s ongoing representation of the Regents of the University of California in UC Santa Barbara’s patent enforcement matter, noting that a recent $1.1 billion verdict for the California Institute of Technology in another matter could bode well for UC Santa Barbara. Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen are the lead attorneys representing UC.
Tech Transfer Central | January 08, 2020
This article quotes Los Angeles Intellectual Property partner Seth Levy discussing Nixon Peabody’s representation of the University of California, which has sued General Electric as part of its ongoing campaign to enforce its patents on LED lightbulb technology. Seth and Los Angeles Intellectual Property partner Shawn Hansen are leading the NP team.
Pacific Coast Business Times | January 02, 2020
Los Angeles Intellectual Property partner Seth Levy is quoted in this story covering the latest developments in UC Santa Barbara’s patent enforcement campaign to protect its LED lightbulb technology, including the addition of General Electric as a defendant. Seth and Los Angeles Intellectual Property partner Shawn Hansen are leading the NP team.
Law360 | August 29, 2019
This article highlights recent developments in the University of California’s campaign to protect its rights related to filament LED technology developed at UC Santa Barbara. On Wednesday, the U.S. International Trade Commission opened an investigation in response to UC’s complaint, filed in July by the Nixon Peabody team led by Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen.
Fast Company | August 02, 2019
This article highlights the University of California’s campaign to protect its rights related to filament LED technology developed at the university. An NP team led by Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen is representing UC in this campaign.
Los Angeles Daily Journal | October 09, 2017
Los Angeles IP litigation partner Shawn Hansen is quoted in this article about drug maker Amgen Inc.’s request for a federal judge to invalidate patents claimed by a rival company so it can create a generic, less expensive version of a popular cancer drug.
10.03.19 | Raleigh, North Carolina
09.20.19 | Seattle, Washington
University of California, Hastings College of the Law, J.D., Senior Articles Editor, Hastings Communications & Entertainment Law Journal
Brigham Young University, B.S., Human Biology
U.S. Court of Appeals, Federal Circuit
U.S. Court of Appeals, Ninth Circuit
U.S. District Court, Northern District of California
U.S. District Court, Central District of California
U.S. District Court, Southern District of California
U.S. Patent and Trademark Office